[go: up one dir, main page]

MX2019002386A - Uso de oligosacaridos de leche humana en el engorde de terneros. - Google Patents

Uso de oligosacaridos de leche humana en el engorde de terneros.

Info

Publication number
MX2019002386A
MX2019002386A MX2019002386A MX2019002386A MX2019002386A MX 2019002386 A MX2019002386 A MX 2019002386A MX 2019002386 A MX2019002386 A MX 2019002386A MX 2019002386 A MX2019002386 A MX 2019002386A MX 2019002386 A MX2019002386 A MX 2019002386A
Authority
MX
Mexico
Prior art keywords
human milk
calves
milk oligosaccharides
present
fattening
Prior art date
Application number
MX2019002386A
Other languages
English (en)
Inventor
Peracha Max
Wemhoff Sabrina
Original Assignee
Oligoscience Biotechnology Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oligoscience Biotechnology Gmbh filed Critical Oligoscience Biotechnology Gmbh
Publication of MX2019002386A publication Critical patent/MX2019002386A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/28—Oligosaccharides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)

Abstract

La presente invención se refiere al uso de oligosacáridos de leche humana para alimentar animales de producción tales como terneros. La presente invención se refiere además a composiciones de pienso de lactancia que contienen oligosacáridos de leche humana. Es contenido adicional de la presente invención un método para prevenir y tratar enfermedades gastrointestinales, particularmente infecciones gastrointestinales, de animales de producción jóvenes, en particular terneros, mediante la administración de una cantidad eficaz de uno o más oligosacáridos de leche humana. Particularmente útil en el contexto de la presente invención como un o el oligosacárido de leche humana es la 2'-fucosil-lactosa (2-FL).
MX2019002386A 2016-08-31 2017-08-29 Uso de oligosacaridos de leche humana en el engorde de terneros. MX2019002386A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16186533 2016-08-31
PCT/EP2017/071606 WO2018041803A1 (en) 2016-08-31 2017-08-29 Use of human milk oligosaccharides in calves fattening

Publications (1)

Publication Number Publication Date
MX2019002386A true MX2019002386A (es) 2019-06-20

Family

ID=56852129

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019002386A MX2019002386A (es) 2016-08-31 2017-08-29 Uso de oligosacaridos de leche humana en el engorde de terneros.

Country Status (11)

Country Link
US (2) US20190183145A1 (es)
EP (1) EP3506768B1 (es)
JP (2) JP2019528088A (es)
KR (2) KR20190045228A (es)
CN (1) CN109788781A (es)
AU (3) AU2017318386A1 (es)
BR (1) BR112019003890A2 (es)
CA (1) CA3035290A1 (es)
MX (1) MX2019002386A (es)
NZ (1) NZ751138A (es)
WO (1) WO2018041803A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7209085B2 (ja) * 2019-06-05 2023-01-19 森永乳業株式会社 組成物
MY199150A (en) * 2019-06-05 2023-10-18 Morinaga Milk Industry Co Ltd Nutritional composition
AU2024266306A1 (en) * 2023-05-04 2025-12-11 Inbiose N.V. Method to reduce feed conversion ratio in a farmed animal

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020019991A1 (en) * 1998-04-30 2002-02-14 Abbott Laboratories Compositions containing an alpha 1,2-fucose linkage and uses thereof
US20080003329A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
MY183602A (en) 2008-12-19 2021-03-02 Chr Hansen Hmo Gmbh Synthesis of fucosylated compounds
CA2757169A1 (en) * 2009-04-13 2010-10-21 Children's Hospital Medical Center Milk oligosaccharide compositions and use thereof in treating infection in animals
SG192234A1 (en) * 2011-02-04 2013-09-30 Univ California Disialyllacto-n-tetraose (dslnt) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease
EP2675899A4 (en) * 2011-02-16 2014-09-10 Glycosyn LLC BIOSYNTHESIS OF HUMAN MILK OLIGOSACCHARIDES IN MANIPULATED BACTERIA
JP6129821B2 (ja) 2011-05-13 2017-05-17 グリコシン リミテッド ライアビリティー カンパニー プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用
NL2007931C2 (en) * 2011-12-07 2013-06-10 Friesland Brands Bv Methods for providing sialylated oligosaccharides and products obtainable thereby.
US10940158B2 (en) * 2013-11-15 2021-03-09 Societe Des Produits Nestle S.A. Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by C-section
EP3191498B1 (en) * 2014-09-12 2020-09-30 Basf Se Method for preparing 2'-o-fucosyllactose
US11318175B2 (en) * 2016-07-01 2022-05-03 Evolve Biosystems, Inc. Method for facilitating maturation of the mammalian immune system

Also Published As

Publication number Publication date
US20210212342A1 (en) 2021-07-15
CA3035290A1 (en) 2018-03-08
CN109788781A (zh) 2019-05-21
AU2017318386A1 (en) 2019-03-21
WO2018041803A1 (en) 2018-03-08
EP3506768A1 (en) 2019-07-10
EP3506768B1 (en) 2026-01-07
AU2022204538A1 (en) 2022-07-21
BR112019003890A2 (pt) 2019-05-21
JP2023123516A (ja) 2023-09-05
US20190183145A1 (en) 2019-06-20
AU2024205177A1 (en) 2024-08-15
JP2019528088A (ja) 2019-10-10
JP7801020B2 (ja) 2026-01-16
KR20190045228A (ko) 2019-05-02
AU2024205177B2 (en) 2026-01-08
KR20240016454A (ko) 2024-02-06
NZ751138A (en) 2025-08-29

Similar Documents

Publication Publication Date Title
PH12016502323A1 (en) Combination, composition, and method of administering the combination or composition to animals
ECSP20084274A (es) Composiciones para animales, y sus usos
EA201592086A1 (ru) Жирная кислота таллового масла для использования в лечении и кормовые добавки и композиции для животных
MX2019009185A (es) Compuesto heterociclico novedoso, su metodo de preparacion y composicion farmaceutica que lo comprende.
BR112013020802A2 (pt) métodos e composições para tratar, reduzir ou impedir dano ao sistema nervoso de animais
BR112017008184A2 (pt) composições e linhagem
EA201791985A1 (ru) Архебактерии в составе биологически активной кормовой добавки, способы получения композиции и способы применения композиции
MX2019002386A (es) Uso de oligosacaridos de leche humana en el engorde de terneros.
BR112018014791A2 (pt) composições para aprimorar a utilização de nitrogênio em um ruminante
EP4302825A3 (en) Pharmaceutical compositions for treatment of inappetence
MX2017004651A (es) Composiciones para incrementar la produccion de grasa lactea en rumiantes lactantes y metodos para utilizar las mismas.
PL409972A1 (pl) Preparat stymulujący poprawę zdrowotności oraz przyrost masy młodych ssaków, zwłaszcza prosiąt, poprawiający wynik tuczu oraz sposób podawania tego preparatu
AR103555A1 (es) Composiciones y métodos para el uso crónico de un compuesto para aumentar el peso
GB2550750A (en) Anthelmintic compounds
BRPI1005541A2 (pt) associação farmacêutica fitoterápica, composição farmacêutica fitoterápica, processo de preparação de composição farmacêutica fitoterápica e seus usos veterinários
BR112016007057A2 (pt) um método veterinário para induzir êmese
AR092733A1 (es) Solucion antiseptica de origen natural utilizada durante la ordeña como baño de pezones (dipping) para la prevencion y control de la mastitis bovina
PH12014502014A1 (en) Animal feed composition containing encapsulated glucono delta-lactone
UA115040U (xx) Спосіб відбору основних свиноматок для штучного осіменіння
UA66841U (ru) СПОСОБ ПАСТЕРИЗАЦИИ НЕКОНДИЦИОННОГО МОЛОКА ОТ БОЛЬНЫХ СУБКЛИНИЧЕСКИМ МАСТИТОМ КОРОВ С СОДЕРЖАНИЕМ В НЕМ STAPHYLOCOCCUS AUREUS ДЛЯ ИСПОЛЬЗОВАНИЯ В КОРМЛЕНИИ ТЕЛЯТ<tab>
UA108238C2 (xx) Антибактеріальна композиція
TH159426A (th) องค์ประกอบอาหารสัตว์ซึ่งมีกลูโคโนเดลต้า-แลคโทนที่ถูกเอนแคปซูเลต
EA201300351A1 (ru) Инъекционная ветеринарная композиция в виде раствора для борьбы с полиинвазиями животного и способ ее получения
NZ752367A (en) Nitrogen utilisation modulation
EA201590527A1 (ru) Фармацевтическая композиция